CVS Health (NYSE:CVS) Stock Rating Reaffirmed by Royal Bank of Canada

CVS Health (NYSE:CVS)’s stock had its “outperform” rating reissued by stock analysts at Royal Bank of Canada. Its target price is $115.00.